{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:32:11Z","timestamp":1791909131887,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.rpth.2023.102143","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T21:04:16Z","timestamp":1688159056000},"page":"102143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-6743","authenticated-orcid":false,"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.102143_bib1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0031-1281028","article-title":"von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib2","first-page":"755","article-title":"Why is misdiagnosis of von Willebrand disease still prevalent and how can we overcome it? A focus on clinical considerations and recommendations","volume":"12","author":"Colonne","year":"2021","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.rpth.2023.102143_bib3","first-page":"17","article-title":"von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0040-1713735","article-title":"Navigating the myriad of von Willebrand factor assays","volume":"40","author":"Favaloro","year":"2020","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.rpth.2023.102143_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jth.13204","article-title":"Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH","volume":"14","author":"Othman","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1569070","article-title":"Treatment of von Willebrand disease","volume":"42","author":"Curnow","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib8","first-page":"338","article-title":"Monitoring therapy during treatment of von Willebrand disease","volume":"43","author":"Favaloro","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.102143_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/jlpm.2017.04.05","article-title":"Reference ranges in hemostasis testing: necessary but imperfect","volume":"2","author":"Favaloro","year":"2017","journal-title":"J\u00a0Lab Precis Med"},{"key":"10.1016\/j.rpth.2023.102143_bib11","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1055\/s-0042-1756188","article-title":"The more recent history of hemophilia treatment","volume":"48","author":"Franchini","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/M19-1208","article-title":"Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries","volume":"171","author":"Iorio","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rpth.2023.102143_bib14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bod\u00f3","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.102143_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.102143_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease in the real world","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.102143_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0042-1753528","article-title":"Evaluating performance of contemporary and historical von Willebrand factor (VWF) assays in the laboratory identification of von Willebrand disease (VWD): the Australasian experience","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib18","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pathol.2021.07.001","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays","volume":"54","author":"Favaloro","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.rpth.2023.102143_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.102143_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12807","article-title":"Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure","volume":"6","author":"Christopherson","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.thromres.2015.12.010","article-title":"Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease","volume":"141","author":"Favaloro","year":"2016","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.102143_bib23","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1111\/jth.14971","article-title":"Comparison of von Willebrand factor platelet-binding activity assays: ELISA overreads type 2B with loss of HMW multimers","volume":"18","author":"Szederjesi","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib24","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/jth.14319","article-title":"Clinically relevant differences between assays for von Willebrand factor activity","volume":"16","author":"Boender","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-4939-7196-1_33","article-title":"Laboratory testing for von Willebrand factor activity by glycoprotein Ib binding assays (VWF:GPIb)","volume":"1646","author":"Patzke","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2023.102143_bib26","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.102143_bib27","article-title":"A\u00a0comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays","volume":"7","author":"Colpani","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-0716-3175-1","article-title":"The role of the von Willebrand factor collagen-binding assay (VWF:CB) in the diagnosis and treatment of von Willebrand disease (VWD) and way beyond: a comprehensive 36-year history","author":"Favaloro","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1579641","article-title":"Type 2M and type 2A von Willebrand disease: similar but different","volume":"42","author":"Favaloro","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1055\/s-0041-1726097","article-title":"Type 2A and 2M von Willebrand disease: differences in phenotypic parameters according to the affected domain by disease-causing variants and assessment of pathophysiological mechanisms","volume":"47","author":"Woods","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/hae.14204","article-title":"How we diagnose 2M von Willebrand disease (VWD): use of a strategic algorithmic approach to distinguish 2M VWD from other VWD types","volume":"27","author":"Favaloro","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.102143_bib33","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/ajh.25618","article-title":"A\u00a0diagnosis of von Willebrand disease despite normal test results for factor VIII and von Willebrand factor antigen and activity","volume":"94","author":"Motum","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2023.102143_bib34","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/jth.14591","article-title":"Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients","volume":"17","author":"Doshi","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib35","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/ajh.26343","article-title":"Is \u2265 100% the magic number to rule out the laboratory diagnosis of von Willebrand disease based on initial testing?","volume":"96","author":"Weyand","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.rpth.2023.102143_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-1-4939-7196-1_34","article-title":"Laboratory testing for von Willebrand factor: factor VIII binding (for 2N VWD)","volume":"1646","author":"Mohammed","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2023.102143_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-4939-7196-1_35","article-title":"Ristocetin-induced platelet aggregation (RIPA) and RIPA mixing studies","volume":"1646","author":"Frontroth","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.rpth.2023.102143_bib38","article-title":"von Willebrand factor multimer analysis and classification: a comprehensive review and updates","author":"Saadalla","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/hae.13396","article-title":"Pre-analytical issues that may cause misdiagnosis in haemophilia and von Willebrand disease","volume":"24","author":"Favaloro","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.102143_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/bloodadvances.2021005946","article-title":"Commentary on \u201cASH ISTH NHF WFH 2021 guidelines on the diagnosis of VWD\u201d: reflections based on recent contemporary test data","volume":"6","author":"Favaloro","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.102143_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.102143_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12635","article-title":"2B von Willebrand disease diagnosis: considerations reflecting on 2021 multi-society guidelines","volume":"5","author":"Othman","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14465","article-title":"The 2021 von Willebrand disease guidelines: clarity and controversy","volume":"28","author":"Makris","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.102143_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/hae.14528","article-title":"Response to \u201cThe 2021 von Willebrand disease guidelines: Clarity and controversy\u201d","volume":"28","author":"James","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.102143_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/hae.14778","article-title":"The 2021 guidelines on the diagnosis of von Willebrand disease: a comparison with current clinical practice in Spanish centers","volume":"29","author":"\u00c1lvarez-Rom\u00e1n","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.rpth.2023.102143_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jtha.2022.11.042","article-title":"Beyond the guidelines: how we approach challenging scenarios in the diagnosis and management of von Willebrand disease","volume":"21","author":"Abou-Ismail","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.102143_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2021005430","article-title":"von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis","volume":"6","author":"Kalot","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.102143_bib47","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1182\/bloodadvances.2021005431","article-title":"Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis","volume":"6","author":"Kalot","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.102143_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0042-1749591","article-title":"Analysis of College of American Pathologists von Willebrand Factor proficiency testing program","volume":"48","author":"Salazar","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib49","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/s-0042-1754332","article-title":"Diagnostic testing for von Willebrand disease: trends and insights from North American laboratories over the last decade","volume":"48","author":"Ziemba","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib50","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1055\/s-0042-1753512","article-title":"External quality assessment data for investigation of von Willebrand disease: focus on relative utility of contemporary functional von Willebrand factor assays. the United Kingdom National External Quality Assessment Scheme (UK NEQAS) experience","volume":"48","author":"Jennings","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib51","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1055\/s-0042-1754354","article-title":"How do laboratories perform von Willebrand disease diagnostics and classification of von Willebrand disease patients? Results from external quality data and an international survey","volume":"48","author":"Hollestelle","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib52","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1055\/s-0042-1754331","article-title":"Laboratory diagnosis of von Willebrand disease (VWD): geographical perspectives","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.102143_bib53","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1111\/hae.14397","article-title":"Diagnosis of von Willebrand disease: an assessment of the quality of testing in North American laboratories","volume":"27","author":"Abdulrehman","year":"2021","journal-title":"Haemophilia"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923001930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:26:51Z","timestamp":1762864011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923001930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2475037923001930"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.102143","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory diagnosis of von Willebrand disease in the age of the new guidelines: considerations based on geography and resources","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.102143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"102143"}}